---
schema_version: "secwatch.filing_event.v1"
accession: "0001217234-24-000089"
form_type: "8-K"
ticker: "CDNA"
cik: "0001217234"
company_name: "CareDx, Inc."
filed_at: "2024-10-04T23:59:59+00:00"
generated_at: "2026-05-30T19:49:57.271375+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# CareDx President of Patient and Testing Services Alexander Johnson departs; receives $817,920 in cash severance

## Summary
- Alexander Johnson, President of Patient and Testing Services, separated without cause on Sept 13, 2024.
- Will receive 6 months base salary plus COBRA premiums, and $517,920 lump sum (200% of 2024 target bonus).
- Also receives $300,000 unpaid retention bonus payable in Dec 2024.
- Signed consulting agreement for up to 40 hrs/month for 6 months; fee $107,901 plus equity vesting.
- Subject to 12-month non-solicitation of employees and mutual non-disparagement.

## SEC filing metadata
- accession: 0001217234-24-000089
- form_type: 8-K
- ticker: CDNA
- cik: 0001217234
- company_name: CareDx, Inc.
- filed_at: 2024-10-04T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1217234/000121723424000089/0001217234-24-000089-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1217234/000121723424000089/cdna-20240930.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001217234-24-000089
- JSON: https://secwatch.observer/filing/0001217234-24-000089.json
- Plain text: https://secwatch.observer/filing/0001217234-24-000089.txt

## Key facts
- Executive change
  Alexander Johnson departed as President of Patient and Testing Services at CareDx, Inc..
  - Action: separated
  - Role: President of Patient and Testing Services
  source text: On September 12, 2024, CareDx, Inc. (the “Company”) announced that the Company reached an agreement with Alexander Johnson, the Company’s President of Patient and Testing Services, pursuant to which Mr. Johnson’s employment would conclude effective as of September 13, 2024 and that such separation would be treated as a termination by the Company without “cause”
  evidence_url: https://www.sec.gov/Archives/edgar/data/1217234/000121723424000089/0001217234-24-000089-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.